Antimicrobial Susceptibility Profiles and Genetic Characteristics of Mycoplasma pneumoniae in Shanghai, China, from 2017 to 2019

References

• Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32(6):956–973. doi:10.1111/j.1574-6976.2008.00129.x
   PubMed Web of Science ®Google Scholar
• Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev. 2017;30(3):747–809. doi:10.1128/CMR.00114-16
   PubMed Web of Science ®Google Scholar
• Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17(4):697–728. doi:10.1128/CMR.17.4.697-728.2004
   PubMed Web of Science ®Google Scholar
• Spuesens EB, Fraaij PL, Visser EG, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10(5):e1001444. doi:10.1371/journal.pmed.1001444
   PubMed Web of Science ®Google Scholar
• Meyer Sauteur PM, Unger WW, Nadal D, Berger C, Vink C, van Rossum AM. Infection with and carriage of Mycoplasma pneumoniae in children. Front Microbiol. 2016;7:329. doi:10.3389/fmicb.2016.00329
   PubMed Web of Science ®Google Scholar
• Dumke R. Molecular tools for typing Mycoplasma pneumoniae and Mycoplasma genitalium. Front Microbiol. 2022;13:904494.
   Web of Science ®Google Scholar
• Cousin-Allery A, Charron A, de Barbeyrac B, et al. Molecular typing of Mycoplasma pneumoniae strains by PCR-based methods and pulsed-field gel electrophoresis. Application to French and Danish isolates. Epidemiol Infect. 2000;124(1):103–111. doi:10.1017/S0950268899003313
   Web of Science ®Google Scholar
• Kenri T, Okazaki N, Yamazaki T, et al. Genotyping analysis of Mycoplasma pneumoniae clinical strains in Japan between 1995 and 2005: type shift phenomenon of M. pneumoniae clinical strains. J Med Microbiol. 2008;57(Pt 4):469–475. doi:10.1099/jmm.0.47634-0
   Web of Science ®Google Scholar
• Sun H, Xue G, Yan C, et al. Multiple-locus variable-number tandem-repeat analysis of mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature. PLoS One. 2013;8(5):e64607. doi:10.1371/journal.pone.0064607
   Web of Science ®Google Scholar
• Chalker VJ, Pereyre S, Dumke R, et al. International Mycoplasma pneumoniae typing study: interpretation of M. pneumoniae multilocus variable-number tandem-repeat analysis. New Microbes New Infect. 2015;7:37–40. doi:10.1016/j.nmni.2015.05.005
   Google Scholar
• Xin D, Mi Z, Han X, et al. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. Antimicrob Agents Chemother. 2009;53(5):2158–2159. doi:10.1128/AAC.01563-08
   PubMed Web of Science ®Google Scholar
• Komatsu H, Tsunoda T, Inui A, Sogo T, Fujisawa T. Characteristics of hospitalized children infected with macrolide-resistant Mycoplasma pneumoniae. Braz J Infect Dis. 2014;18(3):294–299. doi:10.1016/j.bjid.2013.09.004
   Web of Science ®Google Scholar
• Liu Y, Ye X, Zhang H, et al. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China. Antimicrob Agents Chemother. 2009;53(5):2160–2162. doi:10.1128/AAC.01684-08
   PubMed Web of Science ®Google Scholar
• Liu Y, Ye X, Zhang H, et al. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China. Diagn Microbiol Infect Dis. 2010;67(4):355–358. doi:10.1016/j.diagmicrobio.2010.03.004
   Web of Science ®Google Scholar
• Xue G, Li M, Wang N, et al. Comparison of the molecular characteristics of Mycoplasma pneumoniae from children across different regions of China. PLoS One. 2018;13(8):e0198557. doi:10.1371/journal.pone.0198557
   Web of Science ®Google Scholar
• Katsukawa C, Kenri T, Shibayama K, Takahashi K. Genetic characterization of Mycoplasma pneumoniae isolated in Osaka between 2011 and 2017: decreased detection rate of macrolide-resistance and increase of p1 gene type 2 lineage strains. PLoS One. 2019;14(1):e0209938. doi:10.1371/journal.pone.0209938
   Web of Science ®Google Scholar
• Zhao F, Li J, Liu J, et al. Antimicrobial susceptibility and molecular characteristics of Mycoplasma pneumoniae isolates across different regions of China. Antimicrob Resist Infect Control. 2019;8:143. doi:10.1186/s13756-019-0576-5
   PubMed Web of Science ®Google Scholar
• Lee JK, Lee JH, Lee H, et al. Clonal expansion of macrolide-resistant sequence Type 3 Mycoplasma pneumoniae, South Korea. Emerg Infect Dis. 2018;24(8):1465–1471. doi:10.3201/eid2408.180081
   Web of Science ®Google Scholar
• Suzuki S, Konno T, Shibata C, Saito H. Low Incidence of Macrolide-Resistant Mycoplasma pneumoniae between April 2016 and March 2017 in Akita Prefecture, Japan. Jpn J Infect Dis. 2018;71(6):477–478. doi:10.7883/yoken.JJID.2018.170
   Web of Science ®Google Scholar
• Zhao F, Liu J, Shi W, et al. Antimicrobial susceptibility and genotyping of Mycoplasma pneumoniae isolates in Beijing, China, from 2014 to 2016. Antimicrob Resist Infect Control. 2019;8:18. doi:10.1186/s13756-019-0469-7
   PubMed Web of Science ®Google Scholar
• Lucier TS, Heitzman K, Liu SK, Hu PC. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob Agents Chemother. 1995;39(12):2770–2773. doi:10.1128/AAC.39.12.2770
   PubMed Web of Science ®Google Scholar
• Li BB, Shen JZ, Cao XY, et al. Mutations in 23S rRNA gene associated with decreased susceptibility to tiamulin and valnemulin in Mycoplasma gallisepticum. FEMS Microbiol Lett. 2010;308(2):144–149. doi:10.1111/j.1574-6968.2010.02003.x
   Web of Science ®Google Scholar
• Pereyre S, Guyot C, Renaudin H, Charron A, Bébéar C, Bébéar CM. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2004;48(2):460–465. doi:10.1128/AAC.48.2.460-465.2004
   PubMed Web of Science ®Google Scholar
• Dorigo-Zetsma JW, Zaat SA, Wertheim-van Dillen PM, et al. Comparison of PCR, culture, and serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children. J Clin Microbiol. 1999;37(1):14–17. doi:10.1128/JCM.37.1.14-17.1999
   Web of Science ®Google Scholar
• Ieven M, Ursi D, Van Bever H, Quint W, Niesters HG, Goossens H. Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients. J Infect Dis. 1996;173(6):1445–1452. doi:10.1093/infdis/173.6.1445
   Web of Science ®Google Scholar
• Waites KB, Bade DJ, Bébéar C, et al. Methods for antimicrobial susceptibility testing for human mycoplasmas; approved guideline. Clin Lab Stand Inst. 2011;31:19.
   Google Scholar
• Degrange S, Cazanave C, Charron A, Renaudin H, Bebear C, Bebear CM. Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae. J Clin Microbiol. 2009;47(4):914–923. doi:10.1128/JCM.01935-08
   Web of Science ®Google Scholar
• Wang N, Zhou Y, Zhang H, Liu Y. In vitro activities of acetylmidecamycin and other antimicrobials against human macrolide-resistant Mycoplasma pneumoniae isolates. J Antimicrob Chemother. 2020;75(6):1513–1517. doi:10.1093/jac/dkaa027
   Web of Science ®Google Scholar
• Lu CY, Yen TY, Chang LY, Liau YJ, Liu HH, Huang LM. Multiple-locus variable-number tandem-repeat analysis (MLVA) of macrolide-susceptible and -resistant Mycoplasma pneumoniae in children in Taiwan. J Formos Med Assoc. 2020;119(10):1539–1545. doi:10.1016/j.jfma.2019.12.008
   Web of Science ®Google Scholar
• Zhao S, Musa SS, Qin J, He D. Phase-shifting of the transmissibility of macrolide-sensitive and resistant Mycoplasma pneumoniae epidemics in Hong Kong, from 2015 to 2018. Int J Infect Dis. 2019;81:251–253. doi:10.1016/j.ijid.2019.02.030
   PubMed Web of Science ®Google Scholar
• Voronina EN, Gordukova MA, Turina IE, et al. Molecular characterization of Mycoplasma pneumoniae infections in Moscow from 2015 to 2018. Eur J Clin Microbiol Infect Dis. 2020;39(2):257–263. doi:10.1007/s10096-019-03717-6
   Web of Science ®Google Scholar
• Noori Goodarzi N, Pourmand MR, Arfaatabar M, et al. First detection and characterization of macrolide-resistant mycoplasma pneumoniae from people with community-acquired Pneumonia in Iran. Microb Drug Resist. 2020;26(3):245–250. doi:10.1089/mdr.2019.0223
   Web of Science ®Google Scholar
• Waites KB, Duffy LB, Bebear CM, et al. Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum. J Clin Microbiol. 2012;50(11):3542–3547. doi:10.1128/JCM.01439-12
   Web of Science ®Google Scholar
• Lee H, Yun KW, Lee HJ, Choi EH. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Expert Rev Anti Infect Ther. 2018;16(1):23–34. doi:10.1080/14787210.2018.1414599
   PubMed Web of Science ®Google Scholar
• Waites KB, Ratliff A, Crabb DM, et al. Macrolide-resistant Mycoplasma pneumoniae in the United States as determined from a national surveillance program. J Clin Microbiol. 2019;57(11):pii: e00968–00919. doi:10.1128/JCM.00968-19
   Web of Science ®Google Scholar
• Tanaka T, Oishi T, Miyata I, et al. Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015. Emerg Infect Dis. 2017;23(10):1703–1706. doi:10.3201/eid2310.170106
   PubMed Web of Science ®Google Scholar
• Guo Z, Liu L, Gong J, et al. Molecular features and antimicrobial susceptibility of Mycoplasma pneumoniae isolates from paediatric inpatients in Weihai, China: characteristics of M. pneumoniae In Weihai. J Glob Antimicrob Resist. 2022;28:180–184. doi:10.1016/j.jgar.2022.01.002
   Web of Science ®Google Scholar
• Liu Y, Ye X, Zhang H, Xu X, Wang M. Multiclonal origin of macrolide-resistant Mycoplasma pneumoniae isolates as determined by multilocus variable-number tandem-repeat analysis. J Clin Microbiol. 2012;50(8):2793–2795. doi:10.1128/JCM.00678-12
   PubMed Web of Science ®Google Scholar
• Kogoj R, Praprotnik M, Mrvic T, Korva M, Kese D. Genetic diversity and macrolide resistance of Mycoplasma pneumoniae isolates from two consecutive epidemics in Slovenia. Eur J Clin Microbiol Infect Dis. 2018;37(1):99–107. doi:10.1007/s10096-017-3106-5
   Web of Science ®Google Scholar
• Gullsby K, Olsen B, Bondeson K. Molecular typing of mycoplasma pneumoniae strains in Sweden from 1996 to 2017 and the emergence of a new P1 cytadhesin gene, variant 2e. J Clin Microbiol. 2019;57(6):e00049–00019. doi:10.1128/JCM.00049-19
   Web of Science ®Google Scholar
• Yan C, Yang H, Sun H, et al. Diversity in genotype distribution of mycoplasma pneumoniae obtained from children and adults. Jpn J Infect Dis. 2020;73(1):14–18. doi:10.7883/yoken.JJID.2019.037
   Web of Science ®Google Scholar
• Diaz MH, Benitez AJ, Cross KE, et al. Molecular detection and characterization of mycoplasma pneumoniae among patients hospitalized with community-acquired Pneumonia in the United States. Open Forum Infect Dis. 2015;2(3):ofv106. doi:10.1093/ofid/ofv106
   PubMed Web of Science ®Google Scholar
• Qu J, Chen S, Bao F, Gu L, Cao B. Molecular characterization and analysis of Mycoplasma pneumoniae among patients of all ages with community-acquired pneumonia during an epidemic in China. Int J Infect Dis. 2019;83:26–31. doi:10.1016/j.ijid.2019.03.028
   PubMed Web of Science ®Google Scholar
• Whistler T, Sawatwong P, Diaz MH, et al. Molecular characterization of Mycoplasma pneumoniae infections in two rural populations of Thailand from 2009 to 2012. J Clin Microbiol. 2017;55(7):2222–2233. doi:10.1128/JCM.00350-17
   Web of Science ®Google Scholar